2023 Immunology of Fungal Infections GRC/GRS
2023年真菌感染免疫学GRC/GRS
基本信息
- 批准号:10608737
- 负责人:
- 金额:$ 0.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-12-22 至 2023-04-21
- 项目状态:已结题
- 来源:
- 关键词:AIDS populationAcquired Immunodeficiency SyndromeAddressAntifungal AgentsAreaAspergillosisAspergillus fumigatusAutoimmune DiseasesAutoimmune ProcessBasic ScienceBiological ProductsBlood CirculationBrainCOVID-19 patientCandida albicansCellular StressClinicalCollaborationsCommunitiesCritical PathwaysCryptococcusDataDevelopmentDirect CostsDisabled PersonsDiseaseEpidemicEthicsFosteringFundingGenderGenetic Predisposition to DiseaseGoalsHIVHIV/AIDSHealthHost DefenseImmuneImmune responseImmune systemImmunityImmunocompromised HostImmunogeneticsImmunologic Deficiency SyndromesImmunologicsImmunologyImmunosuppressionImmunotherapeutic agentImmunotherapyIndividualInfectionInfectious Skin DiseasesInnate Immune ResponseInternationalLeadershipLung infectionsMS4A1 geneMalignant NeoplasmsMedicalMinorMinorityModelingModern MedicineModernizationMorbidity - disease rateMucormycosisMucous MembraneMycosesOperative Surgical ProceduresOralOrganOrgan TransplantationParticipantPathogenesisPatientsPopulationPostdoctoral FellowPredispositionRaceRecommendationRelaxationReportingRequest for ProposalsResearchResearch PersonnelRiskRobin birdRoleScientistSignal TransductionStressStructureStudentsTNF geneTexasThe science of MycologyTrainingTranslational ResearchVaccinationadaptive immune responsechemotherapyclinically relevantco-infectioncostdesignfrontiergraduate studentimmune modulating agentsimmunoregulationinfection managementinhibitorinsightmeetingsmembermortalityneglectnext generationnovelnovel strategiesnovel therapeuticsnovel vaccinespandemic diseaseparitypathogenpathogenic fungusposterspreventprogramssupportive environmentsymposiumsynergismtherapeutic targetvaccine candidate
项目摘要
PROJECT SUMMARY
This proposal requests partial support for a meeting on the Immunology of Fungal Infections as a part of a
Gordon Research Conference (GRC) and Gordon Research Seminar (GRS) to be held in Galveston, Texas,
January 21-27, 2023. The broad and long-term goal of this conference is to bring together the world's leading
researchers in this rapidly expanding field to foster cross-disciplinary discussions and collaborations. The
meeting is designed to enhance our understanding of anti-fungal immunity with the aim of developing new
insights for controlling these pathogens. The 2023 conference will include a GRS for trainees held immediately
prior to and in conjunction with the GRC. A specific aim of this meeting will be to convene over 40 leading experts
who will present unpublished data and insights within the field of fungal immunology to all attendees. The GRC
program will be structured into 9 sessions that comprehensively cover the various host and fungal factors that
determine innate and adaptive immune responses. Both basic and translational research will be highlighted, with
a major emphasis on cell signaling and stress response of the immune system as well as co-infections. Afternoon
poster sessions will permit all participants to contribute to these topics with the most meritorious abstracts chosen
by the conference Chairs and Vice-Chairs for oral presentations. Every effort will be made to encourage
participation by graduate students and postdoctoral fellows in the GRC. In addition, the GRS will be specifically
aimed at trainees, allowing them to present their research and interact in a relaxing and extra supportive
environment. Every effort will be made to promote gender parity and include racial/ethical minorities and persons
with disabilities. The significance of this application lies in much needed forum provided by the GRC and GRS
to bring together and synergize the members of an international research community working on the immunology
of fungal infections, which remains a highly understudied area. The GRS will have the added value of helping to
train and energize the next generation of researchers in the field. The health relatedness of this application is
that the discussions generated will help define the important questions relating to basic science as well as those
necessary for the development of novel strategies for immunotherapy. With the high levels of mortality and
morbidity associated with these devastating illnesses, the latter are desperately needed.
项目摘要
该提案要求部分支持召开一次关于真菌感染免疫学的会议,
戈登研究会议(GRC)和戈登研究研讨会(GRS)将在德克萨斯州加尔维斯顿举行,
2023年1月21日至27日。本次会议的广泛和长期目标是汇集世界领先的
研究人员在这个迅速扩大的领域,以促进跨学科的讨论和合作。的
会议旨在提高我们对抗真菌免疫的理解,
对控制这些病原体的见解。2023年的会议将包括立即举行的学员GRS
在GRC之前和与GRC一起。这次会议的一个具体目标是召集40多名主要专家
他将向所有与会者展示真菌免疫学领域未发表的数据和见解。集团风险管理委员会
计划将分为9个会议,全面涵盖各种主机和真菌因素,
决定先天性和适应性免疫反应。基础研究和转化研究都将得到强调,
主要强调免疫系统的细胞信号和应激反应以及合并感染。下午
海报会议将允许所有参与者对这些主题做出贡献,并选择最有价值的摘要
会议主席和副主席作口头介绍。我们将尽一切努力鼓励
研究生和博士后研究员参与GRC。此外,GRS将具体
针对学员,让他们展示他们的研究,并在一个轻松和额外的支持互动
环境将尽一切努力促进性别平等,并将种族/民族少数群体和个人包括在内。
残疾人。这个应用程序的意义在于由GRC和GRS提供急需的论坛
将从事免疫学研究的国际研究团体成员聚集在一起,
真菌感染,这仍然是一个高度欠研究的领域。GRS的附加价值在于帮助
培养和激励该领域的下一代研究人员。此应用程序的健康相关性是
所产生的讨论将有助于确定与基础科学有关的重要问题,
这是开发免疫治疗新策略所必需的。由于死亡率高,
这些毁灭性疾病的发病率,后者迫切需要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jatin M Vyas其他文献
Jatin M Vyas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jatin M Vyas', 18)}}的其他基金
Host Responses to Coccidioides by Human Airway Epithelium
人体气道上皮对球孢子菌的宿主反应
- 批准号:
10373208 - 财政年份:2022
- 资助金额:
$ 0.6万 - 项目类别:
Host Responses to Coccidioides by Human Airway Epithelium
人体气道上皮对球孢子菌的宿主反应
- 批准号:
10616716 - 财政年份:2022
- 资助金额:
$ 0.6万 - 项目类别:
MGH Next Generation Physician-Scientist Through Stimulating Access to Research in Residency Program (MGH-Next Gen StARR)
MGH 下一代医师科学家通过促进住院医师研究项目 (MGH-Next Gen StARR)
- 批准号:
10115797 - 财政年份:2020
- 资助金额:
$ 0.6万 - 项目类别:
Control of Type I Interferon Production in Response to Candida albicans
控制白色念珠菌产生的 I 型干扰素的产生
- 批准号:
10375410 - 财政年份:2020
- 资助金额:
$ 0.6万 - 项目类别:
MGH Next Generation Physician-Scientist Through Stimulating Access to Research in Residency Program (MGH-Next Gen StARR)
MGH 下一代医师科学家通过促进住院医师研究项目 (MGH-Next Gen StARR)
- 批准号:
10441143 - 财政年份:2020
- 资助金额:
$ 0.6万 - 项目类别:
Control of Type I Interferon Production in Response to Candida albicans
控制白色念珠菌产生的 I 型干扰素的产生
- 批准号:
10591418 - 财政年份:2020
- 资助金额:
$ 0.6万 - 项目类别:
MGH Next Generation Physician-Scientist Through Stimulating Access to Research in Residency Program (MGH-Next Gen StARR)
MGH 下一代医师科学家通过促进住院医师研究项目 (MGH-Next Gen StARR)
- 批准号:
10655348 - 财政年份:2020
- 资助金额:
$ 0.6万 - 项目类别:
Pathways to Mentorship and Research: Training the Next Generation Physician-Scientists
指导和研究途径:培训下一代医生科学家
- 批准号:
10226306 - 财政年份:2019
- 资助金额:
$ 0.6万 - 项目类别:
Pathways to Mentorship and Research: Training the Next Generation Physician-Scientists
指导和研究途径:培训下一代医生科学家
- 批准号:
10672162 - 财政年份:2019
- 资助金额:
$ 0.6万 - 项目类别:
The Functional Role of the Tetraspanin CD82/Kai1 in Fungal Innate Immunity
四跨膜蛋白 CD82/Kai1 在真菌先天免疫中的功能作用
- 批准号:
10090557 - 财政年份:2018
- 资助金额:
$ 0.6万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 0.6万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 0.6万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 0.6万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 0.6万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 0.6万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 0.6万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 0.6万 - 项目类别: